DFDA

Ciprofloxacin

Treatment for Invasive Non Typhoidal Salmonella Ints

Typical Dosage: 500-750mg orally twice daily or 400mg IV twice daily

Effectiveness
85%
Safety Score
70%
Clinical Trials
250
Participants
25K

Comparative Safety Scale(Higher is safer)

Cyanide☠ī¸
Meth💀
CigarettesđŸšŦ
Chemoâ˜ĸī¸
AlcoholđŸē
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
500-750mg orally twice daily or 400mg IV twice daily
Time to Effect
1-2 days
Treatment Duration
7-14 days
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$50
Monitoring:$500
Side Effect Mgmt:$50
Total Annual:$600
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$706
Cost per Remission
$706
Prescription Access Economics
Physician Visit Cost
$150/year
Time Cost
$50/year
Travel + wait time
Insurance Admin Cost
$20/year
Prior auth, claims
Rx Price
$50/year
Risk Assessment
Misuse Risk
MODERATE
Missed Diagnosis Risk
HIGH
Requires Monitoring
Yes
Needs lab work/checkups
Ciprofloxacin Outcomes

for Invasive Non Typhoidal Salmonella Ints

Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+85%
Remission Rate
+85%
Common Side Effects
Nausea
+4%
Diarrhea
+3%
Headache
+2%
Tendinopathy/Tendon rupture
+0.1%

Sources:

nih.gov
researchgate.net
springermedicine.com

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov